{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:09:48Z","timestamp":1790622588130,"version":"4.1.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T00:00:00Z","timestamp":1654300800000},"content-version":"am","delay-in-days":307,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Foundation for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015382","name":"University of British Columbia Centre for Blood Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.lfs.2021.119482","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T05:15:06Z","timestamp":1618982106000},"page":"119482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["In vitro assessment of anti-fibrotic drug activity does not predict in vivo efficacy in murine models of Duchenne muscular dystrophy"],"prefix":"10.1016","volume":"279","author":[{"given":"Marine","family":"Theret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Rempel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin Wei","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osvaldo","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Kai","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio M.V.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2021.119482_bb0005","doi-asserted-by":"crossref","DOI":"10.1177\/1535370213489441","article-title":"Molecular basis of organ fibrosis: potential therapeutic approaches","author":"Ghosh","year":"2013","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.lfs.2021.119482_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpath.2014.02.003","article-title":"Matrix biology of idiopathic pulmonary fibrosis: a workshop report of the national heart, lung, and blood institute","volume":"184","author":"Thannickal","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2021.119482_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2012.12.007","article-title":"Strategies for anti-fibrotic therapies","volume":"1832","author":"Rosenbloom","year":"2013","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.lfs.2021.119482_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","author":"Henderson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2021.119482_bb0025","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/965631","article-title":"Understanding the process of fibrosis in duchenne muscular dystrophy","volume":"2014","author":"Kharraz","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2021.119482_bb0030","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201402079","article-title":"Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy","volume":"207","author":"Dadgar","year":"2014","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.lfs.2021.119482_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcdb.2016.09.013","article-title":"Fibrosis development in early-onset muscular dystrophies: mechanisms and translational implications","volume":"64","author":"Serrano","year":"2017","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.lfs.2021.119482_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/sj.jid.5700613","article-title":"Formation and function of the myofibroblast during tissue repair","volume":"127","author":"Hinz","year":"2007","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.lfs.2021.119482_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/ncb2015","article-title":"Muscle injury activates resident fibro\/adipogenic progenitors that facilitate myogenesis","volume":"12","author":"Joe","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.lfs.2021.119482_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/ncb2014","article-title":"Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle","volume":"12","author":"Uezumi","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.lfs.2021.119482_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.79","article-title":"Characterization of adipocytes derived from fibro\/adipogenic progenitors resident in human skeletal muscle","volume":"6","author":"Arrighi","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2021.119482_bb0060","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.232157","article-title":"Cross-talk between TGF-\u03b2 and PDGFR\u03b1 signaling pathways regulates the fate of stromal fibro-adipogenic progenitors","volume":"132","author":"Contreras","year":"2019","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.lfs.2021.119482_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2013.10.054","article-title":"A special population of regulatory T cells potentiates muscle repair","volume":"155","author":"Burzyn","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2021.119482_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2013.02.053","article-title":"Type 2 innate signals stimulate fibro\/adipogenic progenitors to facilitate muscle regeneration","volume":"153","author":"Heredia","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2021.119482_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/nm.3869","article-title":"Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro\/adipogenic progenitors","volume":"21","author":"Lemos","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2021.119482_bb0080","article-title":"Glucocorticoids increase adipocytes in muscle by affecting IL-4 regulated FAP activity","author":"Dong","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2021.119482_bb0085","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-018-0251-0","article-title":"Interleukin-15 facilitates muscle regeneration through modulation of fibro\/adipogenic progenitors","author":"Kang","year":"2018","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.lfs.2021.119482_bb0090","doi-asserted-by":"crossref","DOI":"10.1242\/dev.057463","article-title":"Connective tissue fibroblasts and Tcf4 regulate myogenesis","volume":"138","author":"Mathew","year":"2011","journal-title":"Development"},{"key":"10.1016\/j.lfs.2021.119482_bb0095","doi-asserted-by":"crossref","DOI":"10.4161\/cc.9.11.11854","article-title":"Fibro\/adipogenic progenitors: a double-edged sword in skeletal muscle regeneration","volume":"9","author":"Natarajan","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.lfs.2021.119482_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2016.06.007","article-title":"Pharmacological blockage of fibro\/adipogenic progenitor expansion and suppression of regenerative fibrogenesis is associated with impaired skeletal muscle regeneration","volume":"17","author":"Fiore","year":"2016","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.lfs.2021.119482_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.04.074","article-title":"Mesenchymal stromal cells are required for regeneration and homeostatic maintenance of skeletal muscle","volume":"27","author":"Wosczyna","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2021.119482_bb0110","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.086629","article-title":"Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle","volume":"124","author":"Uezumi","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.lfs.2021.119482_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2018.10.077","article-title":"AMPK activation regulates LTBP4-dependent TGF-\u03b21 secretion by pro-inflammatory macrophages and controls fibrosis in Duchenne muscular dystrophy","volume":"25","author":"Juban","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2021.119482_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/path.4801","article-title":"PDGFR\u03b1 signalling promotes fibrogenic responses in collagen-producing cells in Duchenne muscular dystrophy","volume":"240","author":"Ieronimakis","year":"2016","journal-title":"J. Pathol."},{"key":"10.1016\/j.lfs.2021.119482_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2012.10.025","article-title":"Imatinib attenuates severe mouse dystrophy and inhibits proliferation and fibrosis-marker expression in muscle mesenchymal progenitors","author":"Ito","year":"2013","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.lfs.2021.119482_bb0130","article-title":"Role of transforming growth factor \u03b2 in human disease","volume":"343","author":"Blobe","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.lfs.2021.119482_bb0135","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1242\/jcs.02554","article-title":"Non-Smad TGF-beta signals","volume":"118","author":"Heldin","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.lfs.2021.119482_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/cr.2008.328","article-title":"Non-Smad pathways in TGF-\u03b2 signaling","volume":"19","author":"Zhang","year":"2009","journal-title":"Cell Res."},{"key":"10.1016\/j.lfs.2021.119482_bb0145","article-title":"Erratum: targeting the TGF\u03b2 signalling pathway in disease","volume":"11","author":"Akhurst","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2021.119482_bb0150","doi-asserted-by":"crossref","DOI":"10.1359\/jbmr.2002.17.1.15","article-title":"Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage","volume":"17","author":"Kalajzic","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.lfs.2021.119482_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/mus.22094","article-title":"Structure and function of the skeletal muscle extracellular matrix","author":"Gillies","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lfs.2021.119482_bb0160","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4939-6771-1_9","article-title":"Fibro\/adipogenic progenitors (FAPs): isolation by FACS and culture","author":"Low","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.lfs.2021.119482_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/nature10509","article-title":"Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia","author":"Dawson","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2021.119482_bb0170","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.119.315125","article-title":"Dynamic chromatin targeting of BRD4 stimulates cardiac fibroblast activation","volume":"125","author":"Stratton","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2021.119482_bb0175","doi-asserted-by":"crossref","DOI":"10.1007\/s12265-012-9397-0","article-title":"The actin-MRTF-SRF gene regulatory axis and myofibroblast differentiation","volume":"5","author":"Small","year":"2012","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.lfs.2021.119482_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/sj.onc.1204043","article-title":"Ets factors and regulation of the extracellular matrix","volume":"19","author":"Trojanowska","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2021.119482_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-\u03b2 signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2021.119482_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-2836(02)01404-3","article-title":"TAK1 is critical for I\u03baB kinase-mediated activation of the NF-\u03baB pathway","volume":"326","author":"Takaesu","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.lfs.2021.119482_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2005.11.021","article-title":"Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice","volume":"198","author":"Messina","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.lfs.2021.119482_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2008.10.006","article-title":"Treatment with inhibitors of the NF-\u03baB pathway improves whole body tension development in the mdx mouse","author":"Siegel","year":"2009","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.lfs.2021.119482_bb0205","doi-asserted-by":"crossref","DOI":"10.1186\/1476-9255-6-15","article-title":"Inhibition of NF\u03baB by the natural product Withaferin a in cellular models of cystic fibrosis inflammation","volume":"6","author":"Maitra","year":"2009","journal-title":"J. Inflamm."},{"key":"10.1016\/j.lfs.2021.119482_bb0210","article-title":"BRD4 inhibition attenuates inflammatory response in microglia and facilitates recovery after spinal cord injury in rats","author":"Wang","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2021.119482_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.semnephrol.2012.04.003","article-title":"TGF-\u03b2 signaling via TAK1 pathway: role in kidney fibrosis","volume":"32","author":"Choi","year":"2012","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.lfs.2021.119482_bb0220","doi-asserted-by":"crossref","DOI":"10.1038\/jid.2013.28","article-title":"TAK1 is required for dermal wound healing and homeostasis","volume":"133","author":"Guo","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.lfs.2021.119482_bb0225","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0909781107","article-title":"Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis","volume":"107","author":"Inokuchi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2021.119482_bb0230","doi-asserted-by":"crossref","DOI":"10.1038\/75037","article-title":"TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice","volume":"6","author":"Zhang","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2021.119482_bb0235","doi-asserted-by":"crossref","DOI":"10.1007\/s00441-015-2139-2","article-title":"Myostatin induces interstitial fibrosis in the heart via TAK1 and p38","volume":"361","author":"Biesemann","year":"2015","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.lfs.2021.119482_bb0240","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10123","article-title":"TAK1 modulates satellite stem cell homeostasis and skeletal muscle repair","volume":"6","author":"Ogura","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2021.119482_bb0245","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98441","article-title":"TAK1 regulates skeletal muscle mass and mitochondrial function","volume":"3","author":"Hindi","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.lfs.2021.119482_bb0250","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M109.064063","article-title":"Transforming growth factor-\u03b2-activated kinase 1 is an essential regulator of myogenic differentiation","author":"Bhatnagar","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.119482_bb0255","doi-asserted-by":"crossref","DOI":"10.1126\/science.270.5244.2008","article-title":"Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction","volume":"270","author":"Yamaguchi","year":"1995","journal-title":"Science (80-. )"},{"key":"10.1016\/j.lfs.2021.119482_bb0260","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.274.38.27161","article-title":"Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-\u03b2-induced gene expression","volume":"274","author":"Hanafusa","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.119482_bb0265","article-title":"TGF-\u03b2-activated kinase 1 and TAK1-binding protein 1 cooperate to mediate TGF-\u03b2 1 -induced MKK3-p38 MAPK activation and stimulation of type I collagen","volume":"292","author":"Kim","year":"2007","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.lfs.2021.119482_bb0270","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah5084","article-title":"BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure","volume":"9","author":"Duan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lfs.2021.119482_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpath.2013.04.020","article-title":"Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis","volume":"183","author":"Tang","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2021.119482_bb0280","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201105013","article-title":"PAI-1-regulated miR-21 defines a novel age-associated fibrogenic pathway in muscular dystrophy","volume":"196","author":"Ardite","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.lfs.2021.119482_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031937","article-title":"The effects of low levels of dystrophin on mouse muscle function and pathology","volume":"7","author":"van Putten","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2021.119482_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2007.08.029","article-title":"Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice","author":"Zhou","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.lfs.2021.119482_bb0295","article-title":"Skeletal muscle fibrosis in the mdx\/utrn+\/\u2212mouse validates its suitability as a murine model of duchenne muscular dystrophy","volume":"10","author":"Gutpel","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2021.119482_bb0300","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12391","article-title":"Disease course in mdx:Utrophin+\/\u2212 mice: comparison of three mouse models of duchenne muscular dystrophy","author":"McDonald","year":"2015","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.lfs.2021.119482_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2020.01.023","article-title":"Pathogenic potential of Hic1-expressing cardiac stromal progenitors","volume":"26","author":"Soliman","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.lfs.2021.119482_bb0310","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2015.62.4718","article-title":"Tyrosine kinase inhibitor-associated cardiovascular toxicity in chronic myeloid leukemia","volume":"33","author":"Moslehi","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lfs.2021.119482_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2020.05.098","article-title":"High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemia","author":"White","year":"2020","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.lfs.2021.119482_bb0320","doi-asserted-by":"crossref","DOI":"10.1186\/s13395-018-0150-5","article-title":"Nilotinib impairs skeletal myogenesis by increasing myoblast proliferation","volume":"8","author":"Contreras","year":"2018","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.lfs.2021.119482_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007258","article-title":"Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT","volume":"4","author":"Dubreuil","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2021.119482_bb0330","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.161","article-title":"Identification and characterization of PDGFR\u00a0+\u00a0mesenchymal progenitors in human skeletal muscle","volume":"5","author":"Uezumi","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2021.119482_bb0335","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00122.2001","article-title":"Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis","volume":"282","author":"Yokoi","year":"2002","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.lfs.2021.119482_bb0340","doi-asserted-by":"crossref","DOI":"10.1186\/1755-1536-5-S1-S24","article-title":"CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis","volume":"5","author":"Lipson","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.lfs.2021.119482_bb0345","doi-asserted-by":"crossref","DOI":"10.1007\/s00441-015-2343-0","article-title":"Connective tissue cells expressing fibro\/adipogenic progenitor markers increase under chronic damage: relevance in fibroblast-myofibroblast differentiation and skeletal muscle fibrosis","volume":"364","author":"Contreras","year":"2016","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.lfs.2021.119482_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177649","article-title":"ALS skeletal muscle shows enhanced TGF-\u03b2 signaling, fibrosis and induction of fibro\/adipogenic progenitor markers","volume":"12","author":"Gonzalez","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2021.119482_bb0355","doi-asserted-by":"crossref","DOI":"10.1172\/JCI200419603","article-title":"Imatinib mesylate inhibits the profibrogenic activity of TGF-\u03b2 and prevents bleomycin-mediated lung fibrosis","volume":"114","author":"Daniels","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2021.119482_bb0360","article-title":"Imatinib attenuates cardiac fibrosis by inhibiting platelet-derived growth factor receptors activation in isoproterenol induced model","author":"Wang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2021.119482_bb0365","doi-asserted-by":"crossref","DOI":"10.1159\/000327719","article-title":"Effect of nilotinib on bleomycin-induced acute lung injury and pulmonary fibrosis in mice","volume":"82","author":"Rhee","year":"2011","journal-title":"Respiration"},{"key":"10.1016\/j.lfs.2021.119482_bb0370","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2010111158","article-title":"Nilotinib attenuates renal injury and prolongs survival in chronic kidney disease","volume":"22","author":"Iyoda","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2021.119482_bb0375","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-0792-6","article-title":"Nintedanib decreases muscle fibrosis and improves muscle function in a murine model of dystrophinopathy","volume":"9","author":"Pi\u00f1ol-Jurado","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2021.119482_bb0380","article-title":"Antifibrotic activity of sorafenib in experimental hepatic fibrosis: refinement of inhibitory targets, dosing, and window of efficacy in vivo","author":"Hong","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.lfs.2021.119482_bb0385","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddz044","article-title":"Sunitinib promotes myogenic regeneration and mitigates disease progression in the mdx mouse model of Duchenne muscular dystrophy","author":"Fontelonga","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.lfs.2021.119482_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2013.07.013","article-title":"BET bromodomains mediate transcriptional pause release in heart failure","volume":"154","author":"Anand","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2021.119482_bb0395","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1522163112","article-title":"BRD4 is a novel therapeutic target for liver fibrosis","volume":"112","author":"Ding","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2021.119482_bb0400","doi-asserted-by":"crossref","DOI":"10.1002\/emmm.201202096","article-title":"Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice","volume":"5","author":"Mozzetta","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.lfs.2021.119482_bb0405","doi-asserted-by":"crossref","DOI":"10.1101\/gad.234468.113","article-title":"HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles","volume":"28","author":"Saccone","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.lfs.2021.119482_bb0410","doi-asserted-by":"crossref","DOI":"10.3410\/B3-13","article-title":"Sweet memories: epigenetic control in flowering","author":"M\u00fcller","year":"2011","journal-title":"F1000 Biol. Rep."},{"key":"10.1016\/j.lfs.2021.119482_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/S0006-291X(03)01207-5","article-title":"A dominant negative TAK1 inhibits cellular fibrotic responses induced by TGF-\u03b2","volume":"307","author":"Ono","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2021.119482_bb0420","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2019.4344","article-title":"Incremental load training improves renal fibrosis by regulating the TGF-\u03b21\/TAK1\/MKK3\/p38MAPK signaling pathway and inducing the activation of autophagy in aged mice","author":"Bao","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.lfs.2021.119482_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108322","article-title":"CPEB1 or CPEB4 knockdown suppresses the TAK1 and Smad signalings in THP-1 macrophage-like cells and dermal fibroblasts","author":"Cui","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.lfs.2021.119482_bb0430","article-title":"Arginyltransferase knockdown attenuates cardiac hypertrophy and fibrosis through TAK1-JNK1\/2 pathway","author":"Singh","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2021.119482_bb0435","article-title":"TAK1 inhibition improves myoblast differentiation and alleviates fibrosis in a mouse model of Duchenne muscular dystrophy","author":"Xu","year":"2020","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.lfs.2021.119482_bb0440","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.12581","article-title":"A potential therapeutic effect of catalpol in Duchenne muscular dystrophy revealed by binding with TAK1","volume":"11","author":"Xu","year":"2020","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.lfs.2021.119482_bb0445","article-title":"Catalpol counteracts the pathology in a mouse model of Duchenne muscular dystrophy by inhibiting the TGF-\u03b21\/TAK1 signaling pathway","author":"Xu","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.lfs.2021.119482_bb0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218178","article-title":"Yin\/Yang expression of CCN family members: transforming growth factor beta 1, via ALK5\/ FAK\/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts","author":"Peidl","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2021.119482_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/S0014-5793(00)01588-X","article-title":"Phosphorylation-dependent activation of TAK1 mitogen-activated protein kinase kinase kinase by TAB1","author":"Sakurai","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lfs.2021.119482_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2014.08.004","article-title":"Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKK\u03b2","volume":"91","author":"Heyninck","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2021.119482_bb0465","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00248","article-title":"An adaptogen: Withaferin a ameliorates in vitro and in vivo pulmonary fibrosis by modulating the interplay of fibrotic, matricelluar proteins, and cytokines","volume":"9","author":"Bale","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2021.119482_bb0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042989","article-title":"Withaferin-A reduces type I collagen expression in vitro and inhibits development of myocardial fibrosis in vivo","volume":"7","author":"Challa","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2021.119482_bb0475","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00195","article-title":"Withaferin a associated differential regulation of inflammatory cytokines","volume":"9","author":"Dubey","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2021.119482_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2015.12.005","article-title":"Bromodomains: structure, function and pharmacology of inhibition","volume":"106","author":"Ferri","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2021.119482_bb0485","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88032","article-title":"BET inhibitors block pancreatic stellate cell collagen I production and attenuate fibrosis in vivo","volume":"2","author":"Kumar","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.lfs.2021.119482_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2016.12.031","article-title":"Brd4 inhibition attenuates unilateral ureteral obstruction-induced fibrosis by blocking TGF-\u03b2-mediated Nox4 expression","author":"Zhou","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.lfs.2021.119482_bb0495","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1202838","article-title":"BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses","volume":"190","author":"Belkina","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2021.119482_bb0500","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-46516-x","article-title":"Bromodomain inhibitor JQ1 reversibly blocks IFN-\u03b3 production","volume":"9","author":"Gibbons","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2021.119482_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2012.06.008","article-title":"Tyrosine kinase signaling in fibrotic disorders. Translation of basic research to human disease","volume":"1832","author":"Beyer","year":"2013","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.lfs.2021.119482_bb0510","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00149614","article-title":"The role of tyrosine kinases in the pathogenesis of idiopathic pulmonary fibrosis","volume":"45","author":"Grimminger","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lfs.2021.119482_bb0515","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201104053","article-title":"p38\/MKP-1-regulated AKT coordinates macrophage transitions and resolution of inflammation during tissue repair","volume":"195","author":"Perdiguero","year":"2011","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.lfs.2021.119482_bb0520","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19123761","article-title":"Role of p38 MAPK in atherosclerosis and aortic valve sclerosis","volume":"19","author":"Reustle","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2021.119482_bb0525","article-title":"p38 MAP kinase-dependent regulation of endothelial cell permeability","author":"Borbiev","year":"2004","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.lfs.2021.119482_bb0530","doi-asserted-by":"crossref","DOI":"10.1177\/1470320316653284","article-title":"Chronic p38 mitogen-activated protein kinase inhibition improves vascular function and remodeling in angiotensin II-dependent hypertension","volume":"17","author":"Potthoff","year":"2016","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"10.1016\/j.lfs.2021.119482_bb0535","doi-asserted-by":"crossref","DOI":"10.1038\/nm.3465","article-title":"P38 MAPK signaling underlies a cell-autonomous loss of stem cell self-renewal in skeletal muscle of aged mice","author":"Bernet","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2021.119482_bb0540","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2016.00091","article-title":"Regulation of muscle stem cell functions: a focus on the p38 MAPK signaling pathway","volume":"4","author":"Segal\u00e9s","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.lfs.2021.119482_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/bs.pmbts.2017.11.026","article-title":"Wnt signaling in skeletal muscle development and regeneration","author":"Girardi","year":"2018","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.lfs.2021.119482_bb0560","doi-asserted-by":"crossref","DOI":"10.1186\/s13395-018-0186-6","article-title":"Open-CSAM, a new tool for semi-automated analysis of myofiber cross-sectional area in regenerating adult skeletal muscle","author":"Desgeorges","year":"2019","journal-title":"Skelet. Muscle"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521004677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521004677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T13:35:42Z","timestamp":1731591342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521004677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":110,"alternative-id":["S0024320521004677"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119482","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro assessment of anti-fibrotic drug activity does not predict in vivo efficacy in murine models of Duchenne muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119482"}}